ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis

Sustained ANKRD26 expression associated with germline ANKRD26 mutations causes thrombocytopenia 2 (THC2), an inherited platelet disorder associated with a predisposition to leukemia. Some patients also present with erythrocytosis and/or leukocytosis. Using multiple human-relevant in vitro models (ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Basso-Valentina, Francesca, Donada, Alessandro, Manchev, Vladimir T., Lisetto, Manuel, Balayn, Nathalie, Martin, Jean Edouard, Muller, Delphine, Oyarzun, Cecilia Paola Marin, Duparc, Hélène, Arkoun, Brahim, Cumin, Alessandro, Faivre, Lionel, Droin, Nathalie, Biunno, Ida, Pecci, Alessandro, Balduini, Alessandra, Debili, Najet, Antony-Debré, Iléana, Marty, Caroline, Vainchenker, William, Plo, Isabelle, Favier, Remi, Raslova, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Hematopoiesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388282/
https://www.ncbi.nlm.nih.gov/pubmed/36794499
http://dx.doi.org/10.3324/haematol.2022.282049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388282/
https://www.ncbi.nlm.nih.gov/pubmed/36794499
http://dx.doi.org/10.3324/haematol.2022.282049

Ejemplares similares